Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.
about
Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive TechnologyMultiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysisCUA guidelines on prostate biopsy methodology.Calibrating disease progression models using population data: a critical precursor to policy development in cancer controlCombined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.[Focal prostate cancer therapy: capabilities, limitations and prospects].Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.The future perspectives in transrectal prostate ultrasound guided biopsyProstate biopsy for the interventional radiologistClinical value of core length in contemporary multicore prostate biopsyBeyond diagnosis: evolving prostate biopsy in the era of focal therapy.Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational studyShort term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer.Is magnetic resonance/ultrasound fusion prostate biopsy better than systematic prostate biopsy? An updated meta- and trial sequential analysis.Targeted prostate biopsy and MR-guided therapy for prostate cancer.Markers of field cancerization: proposed clinical applications in prostate biopsiesPredicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Detecting Residual or Recurrent Prostate Cancer After Radical Prostatectomy: A Pooled Analysis of 12 Individual Studies.Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.The diagnostic ability of an additional midline peripheral zone biopsy in transrectal ultrasonography-guided 12-core prostate biopsy to detect midline prostate cancerDetection of Significant Prostate Cancer According to Anatomical Areas of Sampling Cores Obtained with Transrectal Systematic 12-Core Biopsy.The impact of PLCO control arm contamination on perceived PSA screening efficacy.Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.The impact of reducing the prostate-specific antigen threshold and including isoform reflex tests on the performance characteristics of a prostate-cancer detection programme.Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens.Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerationsUtility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomyApplications of transrectal ultrasound in prostate cancer.Active surveillance for prostate cancerAccuracy study of a robotic system for MRI-guided prostate needle placementDiagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen.Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.Association and regulation of protein factors of field effect in prostate tissues.Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.Imaging modalities for prostate cancer.Effect of the number of biopsy cores on prostate cancer detection and staging.Novel concepts for risk stratification in prostate cancer.
P2860
Q27008215-30301D50-8D56-4D81-8986-F4B7DD3A8BBCQ28657778-406D8CBB-E400-4AF1-AF6E-BA05DD153741Q30482174-0FAB0A18-2FF1-4788-B2ED-05E8E75DA8D7Q30496883-10E9DF80-91AF-4867-B110-DE131249DB11Q33379495-936538C2-9629-4DC1-8609-32FE7B41A950Q34326169-8C86B540-027D-498F-A8F6-727FF3032B9EQ34448994-9EFD559B-9EBF-44FE-BF01-CD1A0FD35C76Q34608622-89418F07-40D4-4163-A190-06D580D1D871Q34864858-9F8A11BD-E665-4FB7-8A0A-A797857FA66BQ35019408-34A3B756-7E7B-4C1C-A758-B9759BB04A9FQ35416415-ADDF89F8-D9DA-4E03-9B05-2B25E8E9E817Q35550202-9D73FFAF-3584-4834-8321-0037B4811F12Q35587112-00692BE0-B67A-4F3A-9BF7-B93271356A59Q35660802-48DFCE63-01F6-4A09-BB0B-8DC7FBAE7E53Q35678391-AE2C5F76-132E-40D7-86A0-AF45085BF39FQ35700730-3D005DFC-92DF-41B9-B583-45155B7C1748Q35820198-948FA698-39C4-4267-BF43-87F7E377434CQ35933229-C2F1AE34-D9F9-43D3-99EA-638C54518FAFQ35991148-7E7E9D25-AE9B-44C3-AAF0-DD0365EDB45AQ36009824-3F243CE2-0E20-4E87-9B27-1599C31323CFQ36063296-4A27B459-5F9E-4A0C-86E5-5C1056452367Q36177334-F01D1D77-B595-4722-BC8A-77B98612592DQ36430461-B40201D7-1FDA-43B1-A22A-E84F256BC187Q36566483-CA792D89-7F2F-4A46-A39A-A2F511D79681Q36567476-15B88FE2-539F-4A37-A5FA-4DAA39DF0DD6Q36707864-7CE6AA7C-49CA-44CD-AB79-45B10E95FD72Q36837289-0DA6D3DA-1BBB-4158-96C9-9E8940148516Q36906894-103A8C64-FE7B-49C7-BE46-704EB485244CQ36984204-CE3B7F6F-5A0C-4DDA-9E2E-BA85A5AC2D50Q37041973-34DD0F79-C8B9-45C8-8428-7F6169A387B5Q37102542-97366B5B-E43C-4D64-B928-6DBA4A35D066Q37138594-07543766-E95A-45A0-A3C0-19C39C6E733AQ37170437-2C5AD3D7-4B90-4AB0-810F-460137A1B762Q37188997-17AA9D62-4910-43BF-A0CE-6163846121A6Q37240462-BC0B2C5B-4EAE-4C82-A75A-2FAAC5950179Q37252687-AB38DBA2-A5BF-49AE-8A64-955B684DC3B9Q37418080-C1814D80-C71D-4857-A87D-F5D1723E8F85Q37546036-319B9665-7DB4-4B2C-880E-190106FE17AAQ37707378-EE49D5F1-2E47-43E5-A4DA-FDCEC81C1D5FQ37708177-6FBC5A0D-AAD9-4A86-8A6C-0304ED0EE0B5
P2860
Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Diagnostic value of systematic ...... e cancer: a systematic review.
@ast
Diagnostic value of systematic ...... e cancer: a systematic review.
@en
type
label
Diagnostic value of systematic ...... e cancer: a systematic review.
@ast
Diagnostic value of systematic ...... e cancer: a systematic review.
@en
prefLabel
Diagnostic value of systematic ...... e cancer: a systematic review.
@ast
Diagnostic value of systematic ...... e cancer: a systematic review.
@en
P2093
P1476
Diagnostic value of systematic ...... te cancer: a systematic review
@en
P2093
Jennifer Wilby
Jos Kleijnen
Klaus Eichler
Lucas M Bachmann
P304
P356
10.1016/S0022-5347(05)00957-2
P407
P577
2006-05-01T00:00:00Z